DiagnosisOne Unveils New Name, Alere Analytics, at the Healthcare Information Management Systems Society (HIMSS) 2013 Annual

  DiagnosisOne Unveils New Name, Alere Analytics, at the Healthcare
  Information Management Systems Society (HIMSS) 2013 Annual Conference

    Name Reflects Continued Commitment to Healthcare Innovation, Providing
Real-time Clinical Decision Support, Analytics and Meeting Meaningful Use for
                        Hospitals, Providers and EHRs

HIMSS13

Business Wire

LOWELL, Mass. -- March 4, 2013

DiagnosisOne, an Alere subsidiary specializing in analytics and clinical
decision support technology, today announced that the Company will now be
conducting business as Alere Analytics. The name change reflects a continued
focus on providing the healthcare industry with a broad array of analytical
and clinical decision support solutions, including real-time patient and
population assessment. These solutions are delivered through a powerful
platform that integrates Meaningful Use-required interoperability and
accountable-care standards at the point of care.

Alere Analytics, formally known as DiagnosisOne, embarked on a rebranding
campaign after joining Alere in July 2012. The new name distinguishes the
Company as an industry leader in providing intelligent, actionable information
that comprehensively addresses gaps across the healthcare continuum.

“Like the other parts of Alere, we are dedicated to providing patient-centric
solutions that improve health outcomes at the point of care and beyond,” said
Mansoor Khan, Sc.D., Chief Executive Officer of Alere Analytics. “Analytics
and decision support have become increasingly important to providers,
hospitals and payers as they focus on empowering clinicians to make the most
informed decisions and set accountable, value-driven care plans for their
patients. Since our technology platform generates immediate care
recommendations, our solution can trigger earlier interventions, reduce
avoidable errors, and improve overall health outcomes at both a patient and
population level.”

Commenting on the Alere Analytics rebranding, Alere Chief Executive Officer,
Ron Zwanziger, stated, “Clinical decision support and analytics tools play a
vital role in our ability to offer comprehensive health information solutions
by enabling providers to personalize care for each patient, which in turn
contributes to increased treatment effectiveness, improved outcomes, and
reduced costs.”

Alere’s Clinical Decision Support solution leverages what is arguably the
world’s largest library of evidence-based guidelines and activates patient
information via patient-specific recommendations and alerts made at the point
of care and in between doctor visits. Built to meet industry standards such as
HL7v3, CCD and CDA, it can be easily integrated into any hospital HIS,
EHR/PHR, and HIE system’sworkflows. Its analytics tools, which facilitate
population assessment, predictive modeling, and risk stratification, help
providers improve care quality, lower costs, and maximize available incentive
payments from programs that include HEDIS, PQRS, and Meaningful Use.

Key Features of the Alere Clinical Decision Support Solution:

  *Deploys world’s largest rules library of over 30,000 evidence-based rules
    including those covering Meaningful Use (1 & 2), HEDIS and PQRS measures,
    and incorporates all 64 Meaningful Use Stage 2 quality measures.
  *Includes important disease packages for patient and population management
    such as diabetes, COPD and heart failure.
  *Provides trusted analytics from a team of clinicians dedicated to
    translating NQF, CMS and NCQA specifications.
  *Incorporates ICD10/9, SNOMED and LOINC codes, and legacy CPTII and HCPCs
    codes.
  *Includes all Cypress patient test inputs.
  *Connects in-patient and out-patient/ambulatory systems.

Demonstrations can be seen at HIMSS13 booth #3060. To learn more about Alere’s
overall health information solutions for value-driven care, visit the Alere
Accountable Care Solutions booth #3129.

About Alere Analytics

Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with
unparalleled analytics and clinical decision support tools based on a single
platform. The company’s analytics and decision support solution leverages the
world's largest library of evidence-based medical knowledge and integrates
seamlessly with existing hospital and laboratory information systems. It
delivers intelligent and actionable information that ensures improved patient
care, fewer errors and better clinical outcomes. Alere Analytics’ customers
include hospitals, healthcare providers, payers, EHR companies, systems
integrators and government entities. Based in Lowell, Mass., Alere Analytics
was formed as DiagnosisOne in 2003 by a team of physicians and healthcare IT
professionals. In July 2012, DiagnosisOne joined Alere, a leading provider of
near-patient diagnostics and health information solutions, and is now
conducting business as Alere Analytics. For more information about the Company
and its solutions, visit www.DiagnosisOne.com.

About Alere Inc.

By developing new capabilities in near-patient diagnosis, monitoring and
health information technology, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on cardiology, infectious disease, toxicology and diabetes. Alere is
headquartered in Waltham, Massachusetts. For more information regarding Alere,
please visit www.alere.com.

Contact:

Schwartz MSL
Erin Zwirn, 781-684-0770
DiagnosisOne@schwartzmsl.com